Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Triple Fluorescence staining to Evaluate Mechanism-based Apoptosis following Chemotherapeutic and Targeted Anti-cancer Drugs in Live Tumor Cells.

De P, Carlson JH, Leyland-Jones B, Williams C, Dey N.

Sci Rep. 2018 Sep 4;8(1):13192. doi: 10.1038/s41598-018-31575-3.

2.

Plasmid Negative Regulation of CPAF Expression Is Pgp4 Independent and Restricted to Invasive Chlamydia trachomatis Biovars.

Patton MJ, Chen CY, Yang C, McCorrister S, Grant C, Westmacott G, Yuan XY, Ochoa E, Fariss R, Whitmire WM, Carlson JH, Caldwell HD, McClarty G.

MBio. 2018 Jan 30;9(1). pii: e02164-17. doi: 10.1128/mBio.02164-17.

3.

RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.

De P, Carlson JH, Jepperson T, Willis S, Leyland-Jones B, Dey N.

Oncotarget. 2017 Jan 10;8(2):3072-3103. doi: 10.18632/oncotarget.13618.

4.

Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers.

De P, Carlson JH, Wu H, Marcus A, Leyland-Jones B, Dey N.

Oncotarget. 2016 Jul 12;7(28):43124-43149. doi: 10.18632/oncotarget.8988.

5.

Anti-tumor efficacy of BEZ235 is complemented by its anti-angiogenic effects via downregulation of PI3K-mTOR-HIF1alpha signaling in HER2-defined breast cancers.

Dey N, Sun Y, Carlson JH, Wu H, Lin X, Leyland-Jones B, De P.

Am J Cancer Res. 2016 Mar 15;6(4):714-46. eCollection 2016.

6.

Role of "oncogenic nexus" of CIP2A in breast oncogenesis: how does it work?

De P, Carlson JH, Leyland-Jones B, Dey N.

Am J Cancer Res. 2015 Aug 15;5(9):2872-91. eCollection 2015. Review.

7.

Chlamydial Lytic Exit from Host Cells Is Plasmid Regulated.

Yang C, Starr T, Song L, Carlson JH, Sturdevant GL, Beare PA, Whitmire WM, Caldwell HD.

MBio. 2015 Nov 10;6(6):e01648-15. doi: 10.1128/mBio.01648-15.

8.

Chlamydia trachomatis virulence factor CT135 is stable in vivo but highly polymorphic in vitro.

Bonner C, Caldwell HD, Carlson JH, Graham MR, Kari L, Sturdevant GL, Tyler S, Zetner A, McClarty G.

Pathog Dis. 2015 Aug;73(6):ftv043. doi: 10.1093/femspd/ftv043. Epub 2015 Jun 24.

9.

Transcriptional profiling of human epithelial cells infected with plasmid-bearing and plasmid-deficient Chlamydia trachomatis.

Porcella SF, Carlson JH, Sturdevant DE, Sturdevant GL, Kanakabandi K, Virtaneva K, Wilder H, Whitmire WM, Song L, Caldwell HD.

Infect Immun. 2015 Feb;83(2):534-43. doi: 10.1128/IAI.02764-14. Epub 2014 Nov 17.

10.

State boards of nursing and the bridge to quality.

Meyer G, Moran V, Cuvar K, Carlson JH.

J Nurs Educ. 2014 Jul 1;53(7):379-86. doi: 10.3928/01484834-20140617-03. Epub 2014 Jun 17.

PMID:
24971732
11.

Doubling down on the PI3K-AKT-mTOR pathway enhances the antitumor efficacy of PARP inhibitor in triple negative breast cancer model beyond BRCA-ness.

De P, Sun Y, Carlson JH, Friedman LS, Leyland-Jones BR, Dey N.

Neoplasia. 2014 Jan;16(1):43-72. Erratum in: Neoplasia. 2014 Apr;16(4):375. Neoplasia. 2014 Apr;16(4):375.

12.

Infectivity of urogenital Chlamydia trachomatis plasmid-deficient, CT135-null, and double-deficient strains in female mice.

Sturdevant GL, Zhou B, Carlson JH, Whitmire WM, Song L, Caldwell HD.

Pathog Dis. 2014 Jun;71(1):90-2. doi: 10.1111/2049-632X.12121. Epub 2014 Jan 13.

13.

Plasmid-mediated transformation tropism of chlamydial biovars.

Song L, Carlson JH, Zhou B, Virtaneva K, Whitmire WM, Sturdevant GL, Porcella SF, McClarty G, Caldwell HD.

Pathog Dis. 2014 Mar;70(2):189-93. doi: 10.1111/2049-632X.12104. Epub 2013 Nov 11.

14.

Chlamydia trachomatis plasmid-encoded Pgp4 is a transcriptional regulator of virulence-associated genes.

Song L, Carlson JH, Whitmire WM, Kari L, Virtaneva K, Sturdevant DE, Watkins H, Zhou B, Sturdevant GL, Porcella SF, McClarty G, Caldwell HD.

Infect Immun. 2013 Mar;81(3):636-44. doi: 10.1128/IAI.01305-12. Epub 2013 Jan 14.

15.

A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates.

Kari L, Whitmire WM, Olivares-Zavaleta N, Goheen MM, Taylor LD, Carlson JH, Sturdevant GL, Lu C, Bakios LE, Randall LB, Parnell MJ, Zhong G, Caldwell HD.

J Exp Med. 2011 Oct 24;208(11):2217-23. doi: 10.1084/jem.20111266. Epub 2011 Oct 10.

16.

Generation of targeted Chlamydia trachomatis null mutants.

Kari L, Goheen MM, Randall LB, Taylor LD, Carlson JH, Whitmire WM, Virok D, Rajaram K, Endresz V, McClarty G, Nelson DE, Caldwell HD.

Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7189-93. doi: 10.1073/pnas.1102229108. Epub 2011 Apr 11.

17.

Frameshift mutations in a single novel virulence factor alter the in vivo pathogenicity of Chlamydia trachomatis for the female murine genital tract.

Sturdevant GL, Kari L, Gardner DJ, Olivares-Zavaleta N, Randall LB, Whitmire WM, Carlson JH, Goheen MM, Selleck EM, Martens C, Caldwell HD.

Infect Immun. 2010 Sep;78(9):3660-8. doi: 10.1128/IAI.00386-10. Epub 2010 Jun 14.

18.

Host-microbe interaction systems biology: lifecycle transcriptomics and comparative genomics.

Sturdevant DE, Virtaneva K, Martens C, Bozinov D, Ogundare O, Castro N, Kanakabandi K, Beare PA, Omsland A, Carlson JH, Kennedy AD, Heinzen RA, Celli J, Greenberg DE, DeLeo FR, Porcella SF.

Future Microbiol. 2010 Feb;5(2):205-19. doi: 10.2217/fmb.09.125. Review. Erratum in: Future Microbiol. 2010 Mar;5(3):526. Ohmsland, Anders [corrected to Omsland, Anders].

19.

Melanoma proteoglycan modifies gene expression to stimulate tumor cell motility, growth, and epithelial-to-mesenchymal transition.

Yang J, Price MA, Li GY, Bar-Eli M, Salgia R, Jagedeeswaran R, Carlson JH, Ferrone S, Turley EA, McCarthy JB.

Cancer Res. 2009 Oct 1;69(19):7538-47. doi: 10.1158/0008-5472.CAN-08-4626. Epub 2009 Sep 8.

20.

Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine.

Kari L, Whitmire WM, Crane DD, Reveneau N, Carlson JH, Goheen MM, Peterson EM, Pal S, de la Maza LM, Caldwell HD.

J Immunol. 2009 Jun 15;182(12):8063-70. doi: 10.4049/jimmunol.0804375.

21.

Creating attitudinal change through teaching: how a course on "Women and Violence" changes students' attitudes about violence against women.

Currier DM, Carlson JH.

J Interpers Violence. 2009 Oct;24(10):1735-54. doi: 10.1177/0886260509335239. Epub 2009 Jun 2.

PMID:
19491307
22.

Chlamydia trachomatis polymorphic membrane protein D is an oligomeric autotransporter with a higher-order structure.

Swanson KA, Taylor LD, Frank SD, Sturdevant GL, Fischer ER, Carlson JH, Whitmire WM, Caldwell HD.

Infect Immun. 2009 Jan;77(1):508-16. doi: 10.1128/IAI.01173-08. Epub 2008 Nov 10.

23.

The Chlamydia trachomatis plasmid is a transcriptional regulator of chromosomal genes and a virulence factor.

Carlson JH, Whitmire WM, Crane DD, Wicke L, Virtaneva K, Sturdevant DE, Kupko JJ 3rd, Porcella SF, Martinez-Orengo N, Heinzen RA, Kari L, Caldwell HD.

Infect Immun. 2008 Jun;76(6):2273-83. doi: 10.1128/IAI.00102-08. Epub 2008 Mar 17.

24.

Pathogenic diversity among Chlamydia trachomatis ocular strains in nonhuman primates is affected by subtle genomic variations.

Kari L, Whitmire WM, Carlson JH, Crane DD, Reveneau N, Nelson DE, Mabey DC, Bailey RL, Holland MJ, McClarty G, Caldwell HD.

J Infect Dis. 2008 Feb 1;197(3):449-56. doi: 10.1086/525285.

PMID:
18199030
25.

In vivo and in vitro studies of Chlamydia trachomatis TrpR:DNA interactions.

Carlson JH, Wood H, Roshick C, Caldwell HD, McClarty G.

Mol Microbiol. 2006 Mar;59(6):1678-91.

26.

Chlamydia trachomatis polymorphic membrane protein D is a species-common pan-neutralizing antigen.

Crane DD, Carlson JH, Fischer ER, Bavoil P, Hsia RC, Tan C, Kuo CC, Caldwell HD.

Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1894-9. Epub 2006 Jan 30.

27.

Comparative genomic analysis of Chlamydia trachomatis oculotropic and genitotropic strains.

Carlson JH, Porcella SF, McClarty G, Caldwell HD.

Infect Immun. 2005 Oct;73(10):6407-18.

28.

Development and evaluation of evidence-based nursing (EBN) filters and related databases.

Lavin MA, Krieger MM, Meyer GA, Spasser MA, Cvitan T, Reese CG, Carlson JH, Perry AG, McNary P.

J Med Libr Assoc. 2005 Jan;93(1):104-15.

29.

Polymorphisms in the Chlamydia trachomatis cytotoxin locus associated with ocular and genital isolates.

Carlson JH, Hughes S, Hogan D, Cieplak G, Sturdevant DE, McClarty G, Caldwell HD, Belland RJ.

Infect Immun. 2004 Dec;72(12):7063-72.

30.

Molecular basis defining human Chlamydia trachomatis tissue tropism. A possible role for tryptophan synthase.

Fehlner-Gardiner C, Roshick C, Carlson JH, Hughes S, Belland RJ, Caldwell HD, McClarty G.

J Biol Chem. 2002 Jul 26;277(30):26893-903. Epub 2002 May 13.

31.

Assistive technology for people with spinal cord injuries: what physicians need to know.

Carlson JH.

Med Health R I. 2000 Mar;83(3):84. No abstract available.

PMID:
10800353
32.

A review of the use of nursing diagnosis in U.S. nurse practice acts.

Lavin MA, Meyer G, Carlson JH.

Nurs Diagn. 1999 Apr-Jun;10(2):57-64.

PMID:
10633691
33.

Developing self-directed learning modules.

Jenkins TB, Carlson JH, Herrick CA.

J Nurs Staff Dev. 1998 Jan-Feb;14(1):17-22.

PMID:
9661402
34.

Using self-directed learning modules. A literature review.

Herrick CA, Jenkins TB, Carlson JH.

J Nurs Staff Dev. 1998 Mar-Apr;14(2):73-80. Review.

PMID:
9592432
35.

Identification and characterization of thymidylate synthase from Neisseria gonorrhoeae.

Carlson JH, Hill SA.

FEMS Microbiol Lett. 1997 Jun 15;151(2):225-30.

36.

Integration host factor is a transcriptional cofactor of pilE in Neisseria gonorrhoeae.

Hill SA, Samuels DS, Carlson JH, Wilson J, Hogan D, Lubke L, Belland RJ.

Mol Microbiol. 1997 Feb;23(4):649-56.

37.

Promoter strength influences phase variation of neisserial opa genes.

Belland RJ, Morrison SG, Carlson JH, Hogan DM.

Mol Microbiol. 1997 Jan;23(1):123-35.

38.

Menopause and hormone replacement therapy from holistic and medical perspectives.

Herrick CA, Douglas V, Carlson JH.

Issues Ment Health Nurs. 1996 Mar-Apr;17(2):153-68. Review.

PMID:
8707535
39.
40.

Curriculum innovation for preparing nurse educators.

Davis DC, Baker AS, Carlson JH.

J Nurs Educ. 1994 Mar;33(3):141-3. No abstract available.

PMID:
8046513
41.

Influence of dose and route on transmission of encephalomyocarditis virus to swine.

Zimmerman J, Schwartz K, Hill HT, Meetz MC, Simonson R, Carlson JH.

J Vet Diagn Invest. 1993 Jul;5(3):317-21.

PMID:
8396980
42.
44.

Isolation of a cytopathic virus from weak pigs on farms with a history of swine infertility and respiratory syndrome.

Yoon IJ, Joo HS, Christianson WT, Kim HS, Collins JE, Carlson JH, Dee SA.

J Vet Diagn Invest. 1992 Apr;4(2):139-43.

PMID:
1616978
45.
46.

Acute reduction of dopamine levels alters responses of basal ganglia neurons to selective D-1 and D-2 dopamine receptor stimulation.

Carlson JH, Bergstrom DA, Demo SD, Walters JR.

Eur J Pharmacol. 1988 Aug 2;152(3):289-300.

PMID:
2906003
47.

Neurophysiological examination of the role of D-1 dopamine receptors in the regulation of neuronal activity in the basal ganglia.

Walters JR, Carlson JH, Weick BG, Bergstrom DA.

Adv Exp Med Biol. 1988;235:145-58. Review. No abstract available.

PMID:
2976248
48.

D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects.

Walters JR, Bergstrom DA, Carlson JH, Chase TN, Braun AR.

Science. 1987 May 8;236(4802):719-22.

PMID:
2953072
49.

Comparison of IgG Fab conjugates for bluetongue antibody detection by the ELISA.

Snydelaar Hardwicke AC, Carlson JH.

Rev Latinoam Microbiol. 1987 Apr-Jun;29(2):153-5. No abstract available.

PMID:
2830650

Supplemental Content

Loading ...
Support Center